EIQ.XA is trading 34.6% up today at A$1.67 after announcing senior U.S.-focused leadership appointments aimed at accelerating its American expansion and commercial rollout.
- The company has appointed a new CFO and a senior clinical leader to strengthen its capability to scale U.S. operations.
- These strategic hires are intended to support the commercialization of Echo IQ’s cardiac AI solutions in the American market.
- Investors are responding positively to the bolstered leadership team as the company prepares for its next phase of growth.